[go: up one dir, main page]

TR200102999T2 - Stop smoking - Google Patents

Stop smoking

Info

Publication number
TR200102999T2
TR200102999T2 TR2001/02999T TR200102999T TR200102999T2 TR 200102999 T2 TR200102999 T2 TR 200102999T2 TR 2001/02999 T TR2001/02999 T TR 2001/02999T TR 200102999 T TR200102999 T TR 200102999T TR 200102999 T2 TR200102999 T2 TR 200102999T2
Authority
TR
Turkey
Prior art keywords
smoking
assist
patient
stop smoking
manufacture
Prior art date
Application number
TR2001/02999T
Other languages
Turkish (tr)
Inventor
M. Mendel Carl
Graham Stephan
Rotherham Neil
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of TR200102999T2 publication Critical patent/TR200102999T2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu bulus, sigarayi birakmaya yardimci olmak için bir tibbi maddenin imalatina yöneliktir. Daha özel olarak ise, bahsedilen imalat, hastanin, sigarayi birakmadan sonra gelen arzunun üstesinden gelmesinde hastaya yardimci olmak için bir bilesigin, özelde bir fenilsiklobutilbutilaminin etkili bir miktarinin kullanimina iliskindir. Ilave olarak, bahsedilen bilesigin kullanimi sigarayi birakan bir hastada kilo kaybinin engellenmesine iliskindir.This invention is directed to the manufacture of a medical article to assist in quitting smoking. More particularly, said manufacture relates to the use of an effective amount of a compound, in particular a phenylcyclobutylbutylamine, to assist the patient in overcoming the desire after smoking cessation. In addition, the use of said compound relates to the prevention of weight loss in a patient who quits smoking.

TR2001/02999T 1999-01-20 2000-01-19 Stop smoking TR200102999T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11668199P 1999-01-20 1999-01-20
US14824699P 1999-08-11 1999-08-11

Publications (1)

Publication Number Publication Date
TR200102999T2 true TR200102999T2 (en) 2002-04-22

Family

ID=26814491

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2001/02786T TR200102786T2 (en) 1999-01-20 2000-01-19 Auxiliary method to cessation.
TR2001/02999T TR200102999T2 (en) 1999-01-20 2000-01-19 Stop smoking

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2001/02786T TR200102786T2 (en) 1999-01-20 2000-01-19 Auxiliary method to cessation.

Country Status (19)

Country Link
EP (1) EP1150672A1 (en)
JP (1) JP2002535273A (en)
KR (1) KR20010111254A (en)
CN (1) CN1355696A (en)
AU (1) AU2730800A (en)
BG (1) BG105820A (en)
BR (1) BR0007633A (en)
CA (1) CA2359564A1 (en)
CZ (1) CZ20012662A3 (en)
HU (1) HUP0105431A3 (en)
ID (1) ID30432A (en)
IL (1) IL144390A0 (en)
MX (1) MXPA01007388A (en)
NO (1) NO20013575L (en)
NZ (1) NZ513638A (en)
PL (1) PL349002A1 (en)
SK (1) SK10312001A3 (en)
TR (2) TR200102786T2 (en)
WO (1) WO2000043002A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0009026A (en) * 1999-03-19 2003-03-05 Knoll Gmbh Eating Disorder Treatment Method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
JP2675573B2 (en) * 1988-03-31 1997-11-12 科研製薬株式会社 Brain function improver

Also Published As

Publication number Publication date
NZ513638A (en) 2001-09-28
EP1150672A1 (en) 2001-11-07
AU2730800A (en) 2000-08-07
NO20013575D0 (en) 2001-07-19
NO20013575L (en) 2001-09-11
JP2002535273A (en) 2002-10-22
TR200102786T2 (en) 2002-05-21
CN1355696A (en) 2002-06-26
BR0007633A (en) 2002-01-02
HUP0105431A3 (en) 2003-05-28
CA2359564A1 (en) 2000-07-27
WO2000043002A1 (en) 2000-07-27
IL144390A0 (en) 2002-05-23
CZ20012662A3 (en) 2002-08-14
ID30432A (en) 2001-12-06
KR20010111254A (en) 2001-12-17
SK10312001A3 (en) 2002-03-05
MXPA01007388A (en) 2002-07-22
PL349002A1 (en) 2002-06-17
BG105820A (en) 2002-06-28
HUP0105431A2 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
TW200514580A (en) Adhesive preparations
TR200201317T2 (en) Synergistic combination.
NZ515392A (en) Respiratory syncytial virus replication inhibitors
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
GB0105772D0 (en) Use
EE200300033A (en) Cyclopentanoindoles, their use in the preparation of a medicament, and the pharmaceutical composition containing them
HRP20090281T1 (en) 1,2,3,4-TETRASUBSTITUATED INDOL FOR TREATMENT OF RESPIRATORY DISEASES
BR0214343A (en) 11 - Beta - Hydroxy Steroid Dehydrogenase Inhibitors Type 1
WO2002036562A3 (en) 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
DE50311898D1 (en) FREDERICAMYCIN DERIVATIVES AS A MEDICAMENT FOR TUMOR TREATMENT
DE50310516D1 (en) Fredericamycin DERIVATIVES
WO2002069945A3 (en) Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors
CY1110373T1 (en) COOPERATIVE COMBINATION INCLUDING Roflumilast And An Anticholinergic Agent Selected From Teatropin Salts
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
WO2003018059A3 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
UA83057C2 (en) Substituted thiazole-benzoisothiazole dioxide derivatives and use of the same
CR7193A (en) PIRROLOPIRIMIDINAS AS INHIBITORS OF THE KINASA PROTENINE
CY1111396T1 (en) NON-METROCLOPRAMID RISK ADMINISTRATION FOR GASTROPARES
TR200002969T2 (en) Pharmaceutical composition.
MXPA05006889A (en) Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
ATE324112T1 (en) TOPICAL TREATMENT FOR MASTALGIA
MXPA05010161A (en) Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases.
SE0004101D0 (en) New use
DE60305053D1 (en) Pyrimidine derivatives as selective COX-2 inhibitors
MXPA03004023A (en) Condensed pyrazindione derivatives as pde inhibitors.